By Chris Bailey | Monday 21 February 2022
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I have shared my views before on the ‘development and marketing of veterinary products’ company Dechra Pharmaceuticals (DPH), including noting in early September that ‘maybe it is just me finding it easier to appraise future human (than animal) demand scope, but I am going to keep on avoiding this one despite the recent share price falls’. And whilst the shares have romped hugely since their IPO early this century, the stock is down almost 30% during the last six months. So is today’s c. 38 quid share price – after the publication of first half numbers – now cheap or still expensive?
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.
Filed under:
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Time left: 09:58:57